Molecules/ROZANOLIXIZUMAB

ROZANOLIXIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: IgG receptor FcRn large subunit p51 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ROZANOLIXIZUMABROZANOLIXIZUMAB-NOLIRYSTIGGOUCB-7665UCB7665

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ROZANOLIXIZUMAB

Loading drug network...